Evaluation of the diagnostic biopsy approach for children with hepatoblastoma: A report from the Children’s Oncology Group AHEP 0731 Liver Tumor Committee

Space: StayCurrentMD Author: Christopher B. Weldon, Arin L. Madenci, Gregory M. Tiao, Stephen P. Dunn, Max R. Langham, Eugene D. McGahren, Sarangarajan Ranganathan, Dolores H. López-Terrada, Milton J. Finegold, Marcio H. Malogolowkin, Jin Piao, Li Huang, Mark D. Krailo, Rebecka L. Me Published:

Author / Expert

Christopher B. Weldon, Arin L. Madenci, Gregory M. Tiao, Stephen P. Dunn, Max R. Langham, Eugene D. McGahren, Sarangarajan Ranganathan, Dolores H. López-Terrada, Milton J. Finegold, Marcio H. Malogolowkin, Jin Piao, Li Huang, Mark D. Krailo, Rebecka L. Me

Topic overview

Abstract

Background

The histopathological assessment of pediatric liver tumors at presentation is critical to establish a diagnosis, guide treatment, and collect appropriate research samples. The purpose of this study was to evaluate complications associated with different approaches to liver biopsy for newly diagnosed hepatoblastoma.

Methods

Children with hepatoblastoma were enrolled on Children's Oncology Group study AHEP0731 (September 2009–March 2012). This analysis evaluated the study cohort of initially unresectable patients who therefore underwent a biopsy procedure at diagnosis. The primary endpoint was clinically significant postbiopsy hemorrhage, defined as requiring red blood cell transfusion.

Results

We identified 121 children who underwent open (n = 76, 63%), laparoscopic (n = 17, 14%), or percutaneous (n = 28, 23%) liver biopsies. All biopsy procedures yielded adequate tissue for diagnosis. Postbiopsy hemorrhage requiring transfusion occurred after 26% (n = 31) of biopsies. Need for blood product transfusion most frequently occurred following open (n = 27/76, 36%) and laparoscopic (n = 4/17, 24%) biopsies, compared with percutaneous (n = 0/28, 0%) biopsies (p 

Keywords

Hashtags

9 Views
0 Comments

Comments

Loading comments...